US Bancorp
AURA icon

US Bancorp’s Aura Biosciences AURA Stock Holding History

US Bancorp’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07K Buy
292
+212
+265% +$1.52K ﹤0.01% 3865
2026
Q1 		$535 Sell
80
-138
-63% -$792 ﹤0.01% 3997
2025
Q4 		$1.19K Hold
218
– – ﹤0.01% 3833
2025
Q3 		$1.35K Hold
218
– – ﹤0.01% 3796
2025
Q2 		$1.36K Buy
+218
New +$1.27K ﹤0.01% 3919
2025
Q1 		– Sell
-27
Closed -$222 – 4196
2024
Q4 		$222 Buy
+27
New +$254 ﹤0.01% 4073

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

US Bancorp's AURA Position: Q2 2026 in Review

US Bancorp increased its Aura Biosciences (AURA) stake by 265% in Q2 2026, buying an estimated $1.52K and bringing the position to 292 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3865.

US Bancorp first reported a position in AURA in Q4 2024 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • US Bancorp held 292 shares of Aura Biosciences worth $2.07K as of Q2 2026.
  • US Bancorp bought 212 Aura Biosciences shares in Q2 2026, an estimated $1.52K.
  • Aura Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3865 holding.
  • US Bancorp first reported a position in Aura Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.